StartUp Health July 23, 2024
This week’s health innovation funding highlights advancements in AI-powered solutions, improving patient access to care, expanding at-home healthcare options, enhancing patient engagement and privacy, and more.
This week’s reported health innovation funding included:
CytoReason, a Tel Aviv, Israel-based developer of computational disease models for predictive insights, raised $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific. source>
Truvian Health, a San Diego, CA-based provider of a blood testing platform, raised $74M led by Wittington Ventures and Great Point Ventures, with participation from DNS Capital, Medical Excellence Capital, Tao Capital, TYH Capital, and 7wireVentures. source>
Brenig Therapeutics, a Dover, DE-based neurology-focused drug development company utilizing an AI/ML-based discovery platform, raised $65M led by NEA, with participation from OrbiMed, Torrey Pines Investments....